AVLN (Avalyn Pharma) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AVLN Avalyn Pharma Inc AVLN
11 GF Score
Price $28.50
View Full Analysis

What is Avalyn Pharma FCF Margin %?

Avalyn Pharma AVLN -1.01% 11 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates AVLN with a GF Score™ of 11/100. Among 953 Biotechnology companies, Avalyn Pharma ranks worse than 104931.69% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avalyn Pharma's Free Cash Flow for the six months ended in Dec. 2025 was $-81.83 Mil. Avalyn Pharma's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Avalyn Pharma's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Avalyn Pharma's current FCF Yield % is -6.48%.

The historical rank and industry rank for Avalyn Pharma's FCF Margin % or its related term are showing as below:


AVLN's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -79.91
* Ranked among companies with meaningful FCF Margin % only.

Avalyn Pharma FCF Margin % Related Terms

Avalyn Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Avalyn Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avalyn Pharma FCF Margin % Chart

Avalyn Pharma Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Avalyn Pharma Semi-Annual Data
Dec24 Dec25
FCF Margin % 0.00 0.00

AVLN vs TRAX, IMTX, ARDX: FCF Margin % Comparison

For the Biotechnology subindustry, Avalyn Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avalyn Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avalyn Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avalyn Pharma's FCF Margin % falls into.


AVLN
11GF Score
Avalyn Pharma Inc AVLN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avalyn Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avalyn Pharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-81.828/0
= %

Avalyn Pharma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-81.828/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Avalyn Pharma (AVLN) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avalyn Pharma and its competitors. According to the industry distribution chart, Avalyn Pharma ranks #999999 out of 953 companies in the Biotechnology industry.
Is Avalyn Pharma's FCF Margin % too high?
Avalyn Pharma's current FCF Margin % is 0.00%. Based on the distribution chart, Avalyn Pharma ranks #999999 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Avalyn Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Avalyn Pharma's FCF Margin % compare to TRAX and IMTX?
According to the Biotechnology industry distribution chart, Avalyn Pharma ranks #999999 out of 953 companies for FCF Margin %. This places Avalyn Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avalyn Pharma and its competitors. Avalyn Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avalyn Pharma stock overvalued right now?
Avalyn Pharma (AVLN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Avalyn Pharma's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Avalyn Pharma (AVLN), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avalyn Pharma Business Description

Address 105 W First Street, Boston, MA, USA, 02127
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.
11GF Score

Get the complete analysis for AVLN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.50
Price